Sibelium 10mg

Sibelium 10mg

Sibelium 10 mg is used in the prevention of migraine. It contains the active ingredient Flunarizine, which helps improve blood circulation in your brain and prevents muscle activity that triggers migraine. It is effective at preventing migraine attacks that have already started. By preventing and reducing migraine episodes, the medicine can help you carry out daily activities and improve your overall quality of life.   

How to use

Follow a treatment prescribed by a doctor, usually 10 mg daily at night for adult patients aged 18 to 64 years and 5 mg daily for elderly patients aged 65 years and older. If, during this treatment, depressive or other unacceptable adverse reactions occur, treatment should be discontinued. If no significant improvement is noticed after two months of this initial treatment, the patient should be considered a non-responder, and administration should be discontinued. If a patient responds satisfactorily and maintenance treatment is required, the same daily dose should be used, but this time, interrupted by two successive drug-free days every week. Even if the prevention maintenance treatment is successful and well tolerated, it should be interrupted after six months, and it should only be restarted only if the patient relapses. The limited information available for periods longer than twelve months has shown Flunarizine to continue to be effective. Patients should be regularly reviewed to assess their therapeutic response to treatment, and if a sustained attack-free period is established, interruption of Sibelium treatment should be considered.

Precautions

Sibelium is contraindicated in patients with pre-existing symptoms of Parkinson’s disease or extrapyramidal disorders. It is contraindicated in patients with a known hypersensitivity to Flunarizine or any of the other ingredients. Use in patients with current depressive illness or a history of current depression is contraindicated. Flunarizine should not be given to patients with pre-existing symptoms of Parkinson’s disease. It may contribute to depressive symptoms and reveal Parkinsonism, especially in elderly patients. Therefore, it should be taken with caution in such patients.

The recommended dose prescribed by the doctor should not be exceeded. Women with a history of depressive illness may be at particular risk of depression during chronic treatment with this antimigraine drug. Accumulation may occur if used at a higher than recommended with an increased incidence of side effects. Rarely, fatigue may increase progressively during Flunarizine therapy. Patients suffering from rare hereditary problems of galactose intolerance and Lapp lactase deficiency should not take this antimigraine drug. When used in combination with antihypertensive agents, the dosage of Sibelium may be adjusted. Excessive sedation can develop when alcohol or tranquillizers are taken simultaneously with Flunarizine. Pregnant and breastfeeding mothers should talk to their doctor before taking this medicine.    

Side effects

Side effects of using Sibelium 10 mg include nausea, muscle pain, insomnia, constipation, fatigue and runny nose. Some other side effects that may be seen on taking this medicine are increased appetite, stomach discomfort, and breast pain. Flunarizine may also cause sleepiness during the initial days of the treatment, so it is important to avoid driving or operating machinery until you know how this medicine affects you. The medicine may also cause you to gain weight; to prevent it eat a balanced diet and exercise regularly.